James A. Bianco is CEO & President at CTI BIOPHARMA CORP (CTIC). They have made 30 open-market trades across 1 company since 2006, most recently 2016-06-24.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $118K since 2008, against 28 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CTIC | 1,780,133 | $16.2M |
Shares reported on the most recent Form 4, priced at the 2016-06-24 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CTIC | SELL · 10b5-1 | 2016-06-24 | 2016-06-24 | $0.37 | $4K | +0.7% | -2.5% | +8.0% |
| CTIC | SELL · 10b5-1 | 2016-05-27 | 2016-05-27 | $0.45 | $5K | -3.9% | -31.7% | -25.0% |
| CTIC | SELL · 10b5-1 | 2016-04-29 | 2016-04-29 | $0.52 | $5K | -19.2% | -14.3% | -36.7% |
| CTIC | SELL · 10b5-1 | 2016-03-28 | 2016-03-30 | $0.49 | $5K | -3.1% | -2.8% | -30.7% |
| CTIC | SELL | 2016-03-21 | 2016-03-23 | $0.55 | $350K | +0.5% | +8.8% | -21.5% |
| CTIC | SELL · 10b5-1 | 2016-02-26 | 2016-02-26 | $0.63 | $6K | -5.6% | -13.9% | -22.0% |
| CTIC | SELL · 10b5-1 | 2016-02-16 | 2016-02-18 | $0.42 | $42K | -14.3% | -16.8% | -32.1% |
| CTIC | SELL · 10b5-1 | 2016-01-29 | 2016-01-29 | $1.20 | $12K | -75.6% | -55.9% | -57.3% |
| CTIC | SELL · 10b5-1 | 2015-12-28 | 2015-12-30 | $1.26 | $139K | -2.5% | +4.1% | -57.7% |
| CTIC | SELL · 10b5-1 | 2015-11-27 | 2015-11-30 | $1.23 | $12K | -2.5% | +1.7% | -55.2% |
| CTIC | SELL · 10b5-1 | 2015-10-30 | 2015-10-30 | $1.35 | $351K | -2.5% | +1.7% | -1.7% |
| CTIC | SELL | 2015-09-29 | 2015-10-01 | $1.44 | $862K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2015-03-23 | 2015-03-24 | $1.95 | $342K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL | 2014-12-18 | 2014-12-19 | $2.44 | $98K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2014-09-22 | 2014-09-24 | $2.53 | $777K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2014-08-15 | 2014-08-15 | $2.54 | $102K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL | 2014-06-27 | 2014-06-27 | $2.84 | $142K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL | 2014-06-04 | 2014-06-06 | $2.99 | $164K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL | 2014-03-20 | 2014-03-21 | $3.83 | $1.5M | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2013-09-23 | 2013-09-25 | $1.50 | $196K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2013-08-30 | 2013-08-30 | $1.08 | $28K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL | 2013-08-09 | 2013-08-09 | $1.07 | $43K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2013-07-26 | 2013-07-26 | $1.09 | $28K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2013-06-28 | 2013-06-28 | $1.08 | $28K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL | 2013-05-31 | 2013-05-31 | $1.22 | $34K | -2.5% | +1.7% | +1.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.